Intelligence for the professionals advancing medicine

Pharmaceutical decision-making involves multi-billion-pound investments and multi-year timelines. Executives must navigate shifting regulations, scientific breakthroughs, and logistical pressures in a market saturated with unverified information. Pharmatica exists to cut through that noise.

We serve senior pharmaceutical leaders — including managers, directors, VPs, department heads, and C-level executives from companies with 50 or more employees — with verified, expert-led discussions on R&D, clinical trials, manufacturing, regulatory compliance, and market strategy.

Pharmatica is a community of life sciences professionals across the pharmaceutical and life sciences sectors. Our audience includes those making high-stakes decisions, from selecting suppliers and approving trial designs to navigating regulatory submissions and building the infrastructure that delivers medicines to patients. We work with industry leaders globally to ensure each council member brings first-hand, practical experience, with a focus on subject matter experts who are given the space to share in-depth insights on the industry.

Pharmatica is supported by a Scientific Council of expert analysts who serve as hosts, advisors, and contributors across our four series. Council members are drawn from senior roles in pharmaceutical regulation, clinical development, manufacturing operations, and digital health, bringing peer-level credibility to every conversation.

Council members may host individual episodes within their specialist series, contribute to whitepapers and research publications, and advise the editorial team on topic selection and guest vetting. All council members are active practitioners or recently retired senior professionals with current industry relevance.

In addition to podcast episodes, Pharmatica publishes whitepapers and long-form Insight pieces that focus on the pressing topics facing the industry. These research-led publications provide deeper analysis of the themes we explore and are produced in collaboration with our Scientific Council and featured guests.

Whitepapers

Peer-reviewed publications providing evidence-based analysis of specific pharmaceutical challenges, regulatory trends, or technology developments.

Insights

Shorter-form pieces published alongside episodes, providing context, data summaries, and expert commentary on the topics discussed.

Industry coverage

Reporting that spans the topics affecting the pharmaceutical industry and the broader life sciences ecosystem.

All published content is subject to the same editorial standards as our podcast programming. See the Editorial Policy for full details.